137 results on '"Hermelink, Kerstin"'
Search Results
2. RE: Post-traumatic Stress as the Primary Cause for Cognitive Decline—Not the Whole Story, and Perhaps No Story at All
3. Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients
4. Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer
5. Die Auswirkungen der COVID-19-Pandemie aus der Sicht ambulanter Krebspatienten
6. EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
7. Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study
8. Menopausal Status in Breast Cancer Patients with Past Chemotherapy Determines Long-Term Hypoactive Sexual Desire Disorder
9. Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics
10. Die Auswirkungen der COVID-19-Pandemie aus der Sicht ambulanter Krebspatienten.
11. Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics.
12. Chemobrain? – Beeinträchtigungen kognitiver Funktionen im Zusammenhang mit Erkrankung und Therapie
13. „Chemobrain“? Beeinträchtigungen kognitiver Funktionen bei Mammakarzinompatientinnen
14. Acute and Late Onset Cognitive Dysfunction Associated With Chemotherapy in Women With Breast Cancer
15. Late Presentation at Primary Diagnosis of Breast Cancer: Patients’ Personality Characteristics and Attitudes
16. „Chemobrain“? Beeinträchtigungen kognitiver Funktionen bei Mammakarzinompatientinnen
17. Haben Krebspatienten eine bessere Gedächtnisfunktion?
18. Short-Term Effects of Treatment-Induced Hormonal Changes on Cognitive Function in Breast Cancer Patients: Results of A Multicenter, Prospective, Longitudinal Study
19. Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
20. Cognitive Function During Neoadjuvant Chemotherapy for Breast Cancer: Results of a prospective, multicenter, longitudinal study
21. Late Presentation at Primary Diagnosis of Breast Cancer: Patients' Personality Characteristics and Attitudes.
22. Additional file 2: of EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
23. Additional file 1: of EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
24. Kognitive Dysfunktion bei Mammakarzinompatientinnen
25. Factors associated with the decline of psychological support in hospitalized patients with cancer
26. Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages
27. TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC
28. Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients
29. Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
30. Brustkrebs: Trauma-Symptome im Blick behalten
31. „Chemobrain"? Beeinträchtigungen kognitiver Funktionen bei Mammakarzinompatientinnen.
32. Response
33. Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study
34. Alleviating the Breast Cancer Experience: A Plea for Psycho-Oncology
35. 'Chemobrain'? Die kognitive Leistungsfähigkeit von Mammakarzinom-Patientinnen vor und während neoadjuvanter Chemotherapie
36. Brustkrebs: Trauma-Symptome im Blick behalten.
37. Brief Distress Screening in Clinical Practice: Does it Help to Effectively Allocate Psycho-Oncological Support to Female Cancer Inpatients?
38. Onkologie interdisziplinär. Psychoonkologische Ansätze – Bedeutung für die gynäkologische Onkologie?
39. Kontroversen um das „Chemobrain“
40. Listening: Reflections on a Series of Counseling Sessions
41. Two different sides of ‘chemobrain’: determinants and nondeterminants of self‐perceived cognitive dysfunction in a prospective, randomized, multicenter study
42. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
43. Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-Related Post-Traumatic Stress.
44. Immunotherapy: new options in breast cancer treatment
45. Psychoonkologische Ansätze -- Bedeutung für die gynäkologische Onkologie?
46. Kontroversen um das Chemobrain".
47. Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.
48. International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)
49. KAPITEL 15 - Chemobrain? – Kognitive Störungen nach Chemotherapie
50. Autorinnen and Autoren
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.